Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Miscellaneous endocannabinoid-like targets refers to a heterogeneous group of proteins that interact with endocannabinoids and related lipid signaling molecules but are distinct from the classical CB1 and CB2 cannabinoid receptors (PMID: 20550906). This group includes orphan G protein-coupled receptors such as GPR55, GPR18, and GPR119, which are involved in blood pressure regulation, immune cell migration, and metabolic homeostasis (PMID: 21238501). It also encompasses the transient receptor potential vanilloid 1 (TRPV1) ion channel, which mediates pain and heat sensation, and nuclear receptors like peroxisome proliferator-activated receptors (PPAR-alpha and PPAR-gamma) (PMID: 15313881). These targets are of significant interest in pharmacology because they mediate many of the non-psychoactive effects of cannabinoids like cannabidiol (CBD) and endogenous lipids like palmitoylethanolamide (PEA) (PMID: 12520015). Drugs targeting these pathways are being explored for the treatment of chronic pain, epilepsy, obesity, and inflammatory diseases. However, the broad distribution and diverse functions of these targets present challenges in achieving high therapeutic selectivity and avoiding off-target effects.
Modulation of non-canonical cannabinoid receptors and lipid-sensitive signaling pathways including GPCR activation, ion channel gating, and transcriptional regulation via nuclear receptors.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Miscellaneous endocannabinoid-like targets.